Litcius/Paper detail

HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk

Irene Bonaccorsi, Paolo Carrega, Emmanuele Venanzi Rullo, Rosaria Ducatelli, Michela Falco, Josè Freni, Massimiliano Miceli, Riccardo Cavaliere, Vincenzo Fontana, Antonio Giovanni Versace, Gaetano Caramori, Antonio David, Giuseppe Nunnari, Guido Ferlazzo

2021Immunology Letters19 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)MedicineHuman leukocyte antigenOutcome (game theory)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineImmunologyVirologyDiseaseInfectious disease (medical specialty)AntigenMathematical economicsMathematicsOutbreakImmunodeficiency and Autoimmune DisordersDiabetes and associated disordersDermatological and COVID-19 studies
HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk | Litcius